Natera, Inc.

NTRA Healthcare Diagnostics & Research

Natera, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.3 billion, up 35.9% from fiscal 2024.

Revenue
+34.1%
EPS
+34.4%
Free cash flow
−85.8%
Total debt
−0.06%

Quarter to September 2026, against a year earlier

314.16 49.60 −13.64%
Market cap
$52.4B
P/E
0.0×
Fwd P/E
−289×
Dividend yield
—
F-score
6/9
Altman Z
26.84
Beneish M
−2.17
Dividend safety
n/a

Natera, Inc. (NTRA) Book value per share

Alert me on Book value per share

Natera, Inc.'s book value per share at the end of fiscal 2025 was 12.5×, up 30.7% from 9.6× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 13.0×. Over the past ten years it has ranged from 0.5× (fiscal 2017) to 12.5× (fiscal 2025) — the current reading is the highest in ten years. Natera, Inc. ranks 19th of 49 Diagnostics & Research companies by book value per share.

Book value per share, annual

Embed this chart

Annual newest first

Period Book value per share Change
FY2025 12.5× 30.67%
FY2024 9.6× 44.02%
FY2023 6.7× (7.20%)
FY2022 7.2× (0.59%)
FY2021 7.2× 20.19%
FY2020 6.0× 49.79%
FY2019 4.0× 620.70%
FY2018 0.6× 16.61%
FY2017 0.5× (76.90%)
FY2016 2.1× (70.72%)

Quarterly newest first

Period Book value per share Change
Sep 2026 13.0× 2.08%
Jun 2026 12.7× 1.40%
Mar 2026 12.5× 0.10%
Dec 2025 12.5× 37.22%
43 more quarters

Against its own ten years

Low 0.5× High 12.5×
Ten-year median 6.7×
Current reading's percentile 100

Book value per share against peers

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

More on NTRA